In India, 3 in 5 die following cancer diagnosis, women more affected: Study

Q: How long will it take to read this news story?

The story "In India, 3 in 5 die following cancer diagnosis, women more affected: Study" has 610 words across 20 sentences, which will take approximately 3 - 6 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "In India, 3 in 5 die following cancer diagnosis, women more affected: Study" was covered 9 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 273 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #26373082</li><li>URL: https://chronographically.beamstart.com/news/in-india-3-in-5-17403970371914</li></ul>

Business Standard Logo Business Standard 9h ago

In India, 3 in 5 die following cancer diagnosis, women more affected: Study - Business Standard

Quick Summary:

The Indian Council of Medical Research (ICMR) study found that India ranked third highest in cancer incidence, after China and the US, and accounted for over 10 per cent of the world's cancer-related deaths, ranking second after China.

Researchers also projected that in the coming two decades, India will face a formidable challenge in managing deaths related to cancer incidence, with a yearly increase of two per cent in cases as the population ages.

Three in every five people in India succumb to cancer following diagnosis with women bearing a "disproportionate burden" compared to men, an analysis of global cancer data has estimated.